Introduction
In patients with aortic valve stenosis the manifestation of symptoms is a key event associated with a subsequent increase in morbidity and mortality. 1 In current guidelines aortic valve replacement (AVR) is advised for these patients. 2 It is a frequent finding that manifestation of symptoms is not correlated to aortic valve opening area, thus other factors, in addition to valvular stenosis degree, appears to be contributing to the development of symptoms. In some patients, aortic valve stenosis is associated with left ventricular (LV) concentric remodeling and eventually left ventricular hypertrophy (LVH), which may cause the development of endocardial ischaemia in addition to LV diastolic and systolic dysfunction. [3] [4] [5] [6] [7] Consequently, the development of LVH may initiate the development of symptoms in patients with aortic valve stenosis. 8, 9 Hypertrophy is however not always global-it may also be regional; greater wall tension and higher concentration of circumferential fibres in the interventricular septum may induce asymmetrical septal hypertrophy in response to pressure overload. [10] [11] [12] [13] Although this type of regional hypertrophy is common in aortic valve stenosis and arterial hypertension, [14] [15] [16] [17] [18] Multi-detector computed tomography (MDCT) is used increasingly to assess aortic valve calcification, coronary artery disease (CAD) and to evaluate patients considered for transcatheter aortic valve implantation, 2, 19 In addition, MDCT has evolved as a widely available method for the accurate assessment of cardiac chamber volumes and regional LV myocardial thickness. [20] [21] [22] Using contemporary MDCT technology, radiation dose and administered contrast is modest, scan time is low and cardiac measures correlates well with cardiac magnetic resonance (CMR). [20] [21] [22] This study sets out to test the hypothesis that LV regional hypertrophy predicts future symptomatic status and indication for AVR in patients with asymptomatic aortic valve stenosis.
Methods

Study population
Patients with asymptomatic aortic valve stenosis were prospectively recruited from six hospitals in the greater Copenhagen area by screening for the diagnosis registry code for aortic valve stenosis (DI35.0) as previously described in. 23 In this work, we report findings of LV regional wall thickness and patterns of LV regional and global hypertrophy. Inclusion criteria were echocardiographic peak velocity by continuous-wave Doppler > 2.5 m/s and absence of symptoms assessed by the treating cardiologist at the local hospital. Patients with LV ejection fraction (LVEF) < 50%, serum creatinine > 130 mmol/L, age <50 years, allergies to iodine contrast media, and other severe heart valve disease were excluded. All patients included in the study underwent cardiac MDCT and transthoracic echocardiography (TTE) at Rigshospitalet, University of Copenhagen. Treating physicians were blinded to results from MDCT and TTE collected in this study. The study was approved by the local Research and Ethics Committee (J.nr.H-B-2009-027).
MDCT acquisition
Image acquisition was performed using a 320-detector CT (Aquilion One, Toshiba, Japan). Tube voltage (80-120 kV) and current (380-500 mA) were adjusted according to the patient's body mass index (BMI). Beta blockers were administered orally to patients with heart rates >65 bpm and systolic blood pressure > 110 mmHg. Nitroglycerin was administered orally 2 min before the scan. The MDCT scan consisted of a non-contrast enhanced coronary artery calcium score followed by a coronary angiography. Intravenous contrast media (Visipaque 78 mL, 320 mg/mL) was infused with a flow rate of 5 mL/s followed by a saline chaser. Automatic bolus triggering technique was used for initiating image acquisition. The scan was conducted as an ECG-triggered, single beat, single rotation scanning. Only one heart cycle was scanned if the heart rate was optimal (< _65 bpm). In case of irregularity or heart rate >65 bpm, 2 or 3 heart cycles were scanned. Gantry rotation time was 350-400 ms. Images were reconstructed in diastolic best phase, with least myocardial motion and a slice thickness of 0.5 mm and an increment of 0.3 mm.
MDCT image analysis
CAD (stenosis > 50%) was assessed in all patients as previously described. 23 LV segmentation and chamber measurements were obtained using commercially available software (Vitrea 6.6, Vital Images, MN, USA). LV mass and cardiac chamber volumes were measured as previously described. 22 LV hypertrophy (LVH) was defined as a LV mass indexed to body surface area (LVMi) >80 g/m 2 for men and >65 g/m 2 for women. 22 To assess LV concentric and eccentric patterns the ratio between LV mass and diastolic volume (LVM/V ratio) was calculated as previously described in. 14 A concentric LV was defined as a LV M/V ratio >1.44 g/mL for men and >1.19 g/mL for women. 22 Patterns of LV global hypertrophy were assessed according to LV geometry: 'normal LV', 'LV concentric remodelling', 'eccentric LVH', and 'concentric LVH'. 24 For assessment of regional myocardial thickness, LV epicardial and endocardial borders were traced automatically by the software and manual corrections were performed if necessary ( Figure 1A ). Apical and basal borders were manually marked (basal: inferior to the outflow tract; apical: just before the cavity ends) ( Figure 1B) . The software automatically divided the LV into 16 segments based on the American Heart Association (AHA) 17-segment model 25 excluding the apex ( Figure 1A-C) . 'LV asymmetry' was defined as a regional myocardial wall thickness > _ 13.0 mm and >1.5Â the thickness of the opposing segment as previously described. 14, 26 Accordingly, LV asymmetry and LV geometry characterized the LV into eight unique structural phenotypes ( Figure 2) . Inter-and intraobserver variability of the regional myocardial wall thickness was assessed in 25 randomly selected patients by two experienced observers blinded to all clinical data and previous measurements. Intraobserver analysis was performed with >1 month between repeated measures.
Transthoracic echocardiography
All examinations were performed on a Vivid E9 scanner (GE Healthcare, Horten, Norway) with a 3.5 MHz transducer as previously described in. 23 Images were obtained and digitally transferred to a remote workstation for offline analysis (EchoPac BT 11.1.0, GE Healthcare, Horten, Norway). All measures regarding the aortic valve, LVEF, left ventricular mass, and relative wall thickness were performed as recommended. 27, 28 Severity of aortic valve stenosis was graded according to Doppler estimated effective orifice area in mild (>1.5 cm 
Clinical endpoints
A combined clinical endpoint was defined as clinical indication for AVR as assessed by the Heart-team at Rigshospitalet or sudden cardiac death. Endpoints were recorded at least 18 months after study inclusion. Information on mortality, indication of AVR, and surgical procedure was obtained from electronic health records by a systematic review of hospital contact (outpatient visits and acute admissions). The reviewers were blinded to all MDCT and TTE data.
Statistical analysis
All statistical analysis was completed using R version 3.2.1 (R Foundation for Statistical Computing, Vienna, Austria). Normal distribution was examined by Q-Q plots and normality tests (Kolmogorov-Smirnov, ShapiroWilk). Continuous variables with normal distribution are presented as mean (SD) and compared using Student's t-test. Those with non-normal distribution are presented as median (interquartile range; IQR) and compared using Mann-Whitney U test. Categorical variables are presented as n (%) and compared using Fisher's exact test. To determine independent predictors of adverse outcome, uni-and multivariate Cox proportional hazards regression were used. Pro-BNP and LVEF were right skewed and therefore log transformed before regression analysis. Kaplan-Meier curves were used to estimate outcome distribution according to pattern of LV asymmetry, log-rank tests were used to estimate differences. P-values < 0.05 in two-sided tests were considered statistically significant.
Results
Of 116 eligible patients LV regional thickness could be assessed in 114 patients (2 patients were excluded due to poor image quality). , with 9 (8%) having mild, 40 (35%) moderate, and 65 (57%) severe AS. The image acquisition phase did not differ significantly between patients with LV asymmetry and those without, nor did it differ significantly between the four groups of geometry. Inter-and intraobserver agreement for the assessment of regional thickness showed good correlation (Interobserver: r > 0.94 for all 16 segments; Intraobserver r > 0.96 for all 16 segments).
Patterns of Left ventricular hypertrophy
Clinical characteristics, TTE, and MDCT findings of patients according to pattern of LV asymmetry are given in Table 1 . LV asymmetry was most frequently located to the basal region of the interventricular septum ( Figure 3A) . Representative CT-images are given in Figure 3B -F. LV asymmetry was found in 34 (30%) patients and was more frequent in men. Among patients with LV asymmetry, 22 (65%) had one asymmetrical segment, 9 (26%) had two, and 3 (9%) had three asymmetrical segments. Patients with LV asymmetry had more severe aortic valve stenosis reflected by a higher peak velocity and mean gradient. Similarly, a higher degree of valvular calcification by MDCT was observed in these patients. Patients with LV asymmetry were also characterized by a higher LVMi and LV M/V ratio. Consequently, concentric LVH was more frequent and normal LV geometry less frequent in patients with LV asymmetry (Table 1, bottom).
Clinical outcome
Patients were followed for a median of 2.2 years (IQR 1.6-3.6). 46 patients (40%) reached the endpoint of AVR indication and no patients experienced sudden cardiac death. In no patients undergoing AVR the surgeon deemed it necessary to perform septal myectomy.
During follow-up seven patients where censored due to non-cardiac deaths. No patients were lost to follow-up. The indication for AVR was development of symptoms (n = 45) and reduced LVEF (n = 1). Nine patients did not have surgery due to cancer (n = 2), dementia (n = 2), excessive obesity (n = 1), declined (n = 3), and one patient died a sudden cardiac death awaiting AVR. Median time from baseline examination to indication for AVR was 17 months (IQR 6-26 months).
Patterns Left ventricular hypertrophy and clinical outcome
Kaplan-Meier curves for event-free survival according to pattern of LV asymmetry are given in Figure 4 . In univariate Cox analysis, patients with LV asymmetry had a higher risk of AVR ( Table 2) . Concentric LVH, Pro-BNP, peak velocity, and AV calcification were also predictors of AVR in univariate analysis. In contrast, lower LVEF or CAD was not associated with a higher risk of AVR. In multivariate Cox analysis, pro-BNP, and LV asymmetry were identified as independent predictors of future AVR (Table 3) . Among patients with asymptomatic severe aortic valve stenosis LV asymmetry remained the only independent predictor of future AVR (Supplementary data online, Table S1 ). Figure 5 illustrates univariate risk of AVR according to patterns of LV asymmetry and LV geometry. Patients with normal LV geometry were at higher risk of AVR if LV asymmetry was present rather than absent (HR: 5.10; 95% CI: 1.09-23.79; P ¼ 0.04). Patients with LVH (eccentric or concentric) were also at higher risk of AVR if LV asymmetry was present rather than absent (HR: 3.09; 95% CI: 1.38-6.93; P = 0.006). Among patients with LV asymmetry, the number of asymmetrical segments was not significantly associated to the risk of AVR (HR: 1.16; 95% CI: 0.62-2.14; P = 0.65). The accuracy of LV B C A Figure 1 Segmentation of the left ventricle. The endocardial and epicardial borders of the left ventricle was defined by an automated border detection algorithm. Careful manual correction was performed to avoid any inclusion of the left or right ventricular cavity, papillary muscles, trabeculation, or any extra-cardiac tissue (A). Apical borders were marked just before the cavity ends and basal borders were marked inferior to the outflow tract (B). Automated segmentation of the LV myocardium was based on the standard AHA 17 segment model excluding the apex (C). The orientation of the segments was automatically distributed after manual detection of an axis perpendicular to septum (A). Segments 1-6 defined the basal region, segments 7-12 the mid region and segments 13-16 the apical region (C).
. . . . . . . . . . . asymmetry to predict subsequent AVR had a specificity of 82%, sensitivity of 48%, positive predictive value of 65%, and a negative predictive value of 70%. When combining LV asymmetry with pro BNP, specificity was 64%, sensitivity was 77%, positive predictive value of 81%, and a negative predictive value of 59%.
Discussion
The major finding of this study is that LV regional hypertrophy rather than LV global hypertrophy, has a principal influence on clinical outcome in patients with asymptomatic aortic valve stenosis. Accordingly, the highest frequency of AVR was found in patients with LV asymmetry, encouraging a more detailed evaluation of the myocardium in patients with asymptomatic aortic valve stenosis.
Patterns of Left ventricular hypertrophy
In the wall-stress hypothesis, Grossman 12 states that myocytes thicken in response to increased wall tension. Due to a larger bending radius, tension is greatest in the interventricular septum. 11 This, together with a larger concentration of circumferential fibres, makes the interventricular septum the predilection site of regional myocyte thickening in response to pressure overload. [11] [12] [13] [14] In accordance,
Patterns of LV regional hypertrophy
Patterns of LV global hypertrophy (LV Geometry)
No regional hypertrophy in the form of LV asymmetry has been reported to develop as a physiological response to strenuous exercise in young healthy males. 26 Others have speculated that LV asymmetry develops as an adaptive mechanism maintaining adequate ejection fraction in borderline hypertension. 18 LV asymmetry has however mostly been reported to develop under more severe conditions; sustained hypertension, 17 aortic valve stenosis, 14, 15 and hypertrophic cardiomyopathy (HCM). 29 Indeed, we found LV asymmetry to be present in 30% of patients with asymptomatic aortic valve stenosis. In line with previous studies, 14,15 these patients were characterized by more progressive valve disease, larger LV mass index, together with an increased LV mass per volume ratio compared with those with no LV asymmetry. However, while previous studies on aortic valve stenosis have also reported a higher prevalence of hypertension among patients with LV asymmetry, 14, 15 this study does not find such an association. The reason is not entirely apparent but may be explained by difference in patient selection used. The mean LV maximal wall thickness was 16 mm in patients with LV asymmetry. According to current guidelines, a diagnosis of HCM should be considered if the LV maximal wall thickness exceeds 15 mm-in some cases already if it exceeds 13 mm. 29 In line with previous studies, 14, 26 our data imply a considerable overlap between the morphological appearances of HCM and aortic valve stenosis, making the diagnosis of HCM challenging in the presence of LV pressure overload. As initially hypothesized by Yokota et al., 16 it may however also be possible that these two conditions overlap in aetiology: hypertensive patients with LV asymmetry have a higher incidence of familial occurrence of HCM and a high degree of myocardial fibre disarray (hallmark sign of HCM). A more recent study by Bick et al.
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supports the findings presented by Yokota, reporting rare sarcomere variants in 11.2% of the general population and pathogenic variants in 0.6%, much higher than the 0.2% anticipated to have HCM. 29 Currently however, no definitive assertion can be made on the role of genetics in the development of LV asymmetry-and further research in this field is warranted.
Patterns of left ventricular hypertrophy and clinical outcome
In terms of risk stratification, patterns of LV global hypertrophy have-independent of aetiology-been long proven and are used on TTE, CMR, and MDCT. 8, 9, 14, 22, 24, 31, 32 The progression of aortic valve stenosis, promotes the development of LV concentric remodelling and eventually LVH. Under these conditions myocardial oxygen demand increases while coronary flow reserve decreases and preferential coronary flow shifts from the endocardium to the epicardium, ultimately leading to subendocardial ischaemia and fibrosis. [6] [7] [8] Furthermore, systolic and diastolic function deteriorates as the proportion of non-contractile elements increases as hypertrophy advances. [3] [4] [5] Indeed our univariate analysis confirmed previous findings that both LVH and having a concentric LV is associated with the progression to AVR. This study is the first to report on the prognosis of LV regional hypertrophy. We add to current knowledge by identifying patients with LV asymmetry as a high-risk group with more than three times the risk of AVR compared with those without LV asymmetry. Although LV asymmetry often co-existed with abnormal LV geometry, patients with LVH had more than three times the risk of AVR if LV asymmetry was also present and patients with normal LV geometry had more than five times the risk of AVR if LV asymmetry was present. Furthermore, while the aim of the study was to examine unselected patients with aortic valve stenosis referred to cardiology out-patients clinics, the clinically most challenging patients are those with severe aortic valve stenosis, in these patients LV asymmetry remained an independent predictor of future AVR.
Although the mechanism for the development of symptoms in patients with LV asymmetry is unknown, a mechanism similar to those promoting symptoms in global hypertrophy may be proposed: the increased myocardial oxygen demand in the interventricular septum together with an increased wall stress, promotes the development of a subendocardial ischaemia and impaired contractile function, ultimately causing symptoms.
Our data suggests that the location of hypertrophy may be more important for symptomatic status than the extent of hypertrophy-and while our findings only apply to patients with asymptomatic aortic valve stenosis, one might expect similar findings in other pressureoverloaded conditions. Multicentre studies involving a larger cohort, need to examine this hypothesis, and may pave the way for the assessment of LV regional hypertrophy to be a part of the standard evaluation of patients with pressure-overloaded conditions.
Limitations
It is in order to note some limitations of our work. The patient cohort was recruited from six hospitals in the greater Copenhagen area and regional differences of referral policy and diagnostic strategy may have influenced the characteristics of the final study group. Accordingly, potential selection bias in addition to the modest number of included patients should be taken into account when interpreting our results. LV asymmetry was defined according to current inuse definitions. 14, 26 A more comprehensive definition of LV asymmetry based on normal values of the LV morphology is currently not available, but may be provided in future studies. Forty-six patients developed indication for AVR, but no patients reached our other primary outcome of sudden cardiac death. In all but one, indication for AVR was due to development of symptoms. Cardinal symptoms of aortic valve stenosis may be masked by decreased activity levels in elderly patients and vice versa, making indication for AVR a less than optimal outcome parameter.
Although MDCT is widely used to assess CAD, it is currently not clinical practice to examine patients with asymptomatic aortic valve stenosis using MDCT. Future studies need to examine whether LV asymmetry, as assessed in the current study with MDCT, may be appropriately delineated using TTE.
Global hypertrophy is associated with the presence of myocardial fibrosis. 3 To what extent fibrosis is present in patients with only regional hypertrophy was not evaluated in this study. CMR would, in addition to being radiation-free, allow for the detailed assessment of myocardial fibrosis, and although being clinically less available than MDCT, it should be considered for future studies of LV regional hypertrophy.
Conclusions
This study demonstrates that assessment of LV. regional hypertrophy provides important prognostic information in patients with asymptomatic aortic valve stenosis. LV asymmetry could serve as a clinical Figure 5 Hazard ratio of events according to pattern of LV asymmetry and geometry. Patients with LV asymmetry (right panel) had an overall higher risk of AVR than those with no LV asymmetry (left panel). *P < 0.05 compared with patients with a normal LV and no LV asymmetry.
